Floatz logo

[18F]AlF-OC

Stroke (CVA) or TIA

Universitaire Ziekenhuizen KU LeuvenPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

132 Active assets in the Stroke (CVA) or TIA cohort.

Asset / SponsorPhaseRating
INCOBOTULINUMTOXINA
Parc de Salut Mar
Phase 4BBB
Aggrenox
Boehringer Ingelheim
Phase 4BBB
ATENOLOL
Northern California Institute of Research and Education
Phase 4BBB
Dextromethorphan
University of Florida
Phase 4BBB
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB

View all 50 →

Same molecule, other indications

[18F]AlF-OC is also rated in:

carotid stenosisDormant
CCC
Indicative ·
53 / 100
View asset →
atherosclerotic cardiovascular diseaseDormant
CCC
Indicative ·
53 / 100
View asset →
atherosclerosisDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →